Mark Fereshteh
Affiliations: | Duke University, Durham, NC |
Google:
"Mark Fereshteh"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Harikrishnan LS, Warrier J, Tebben AJ, et al. (2018) Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI). Bioorganic & Medicinal Chemistry |
| Fereshteh MP, Li X, Li S, et al. (2016) Development of a Human Whole Blood Screening Platform to Monitor JAK/STAT Signaling Using High-Throughput Flow Cytometry. Journal of Biomolecular Screening |
| Kotula JW, Sun J, Li M, et al. (2014) Targeted disruption of β-arrestin 2-mediated signaling pathways by aptamer chimeras leads to inhibition of leukemic cell growth. Plos One. 9: e93441 |
| Fereshteh M, Ito T, Kovacs JJ, et al. (2012) β-Arrestin2 mediates the initiation and progression of myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 109: 12532-7 |
| Kim J, Tang JY, Gong R, et al. (2010) Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell. 17: 388-99 |
| Zhao C, Chen A, Jamieson CH, et al. (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 458: 776-9 |
| Oh AS, Lahusen JT, Chien CD, et al. (2008) Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells. Molecular and Cellular Biology. 28: 6580-93 |